Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
, Reliability and Trust (SnT) at the University of Luxembourg is a leading international research and innovation centre in secure, reliable and trustworthy ICT systems and services. We play an instrumental role
-
, including but not limited to cancer, metabolic disorders, and infections. The research design involves the integration of large-scale biological datasets derived from both the host and the microbiome
-
At Helmholtz Munich, we develop groundbreaking solutions for a healthier society in a rapidly changing world. We believe that diverse perspectives drive innovation. Through strong partnerships, we accelerate
-
the key features of real leaves, and conduct similar experiments in the wind tunnel and in a commercial leaf gas exchange apparatus (LI-6800), with the goal of testing hypotheses about the effect of leaf
-
the development of professional skills; supervision by senior scientist incorporating individual development plan in support of training goals and those of faculty mentor; and publication of research findings
-
; · Experience in using NMR, GPC, FTIR, DMA, dilatometry, DSC, TGA, or mechanical testing will be considered as an asset; · Notions in life cycle assessment (LCA) and the safe and sustainable by design
-
Ideal candidates will have: • A Ph.D. in pharmacology, microbiology, cancer biology, chemical biology, or a related field • Experience designing, executing, analyzing, and interpreting quantitative
-
Infection Biology (www.leibniz-hki.de I https://www.leibniz-hki.de/en/ ) have launched the SynThera initiative (www.synthera.eu ) funded by the Carl Zeiss Foundation, which aims to design, create, and deploy
-
. Positions are available in the following Faculties/Schools/Departments/Laboratories: - Department of Architecture - Department of Real Estate and Construction - Department of Urban Planning and Design
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe